Wait, we have a special
offer for you!
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Only Available By Prescription
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Vyepti (Eptinezumab) is a prescription medication designed for the preventive treatment of migraine in adults. It belongs to a class of drugs known as monoclonal antibodies, specifically targeting the calcitonin gene-related peptide (CGRP) pathway, a key player in the onset of migraine headaches. Administered via intravenous infusion, Vyepti works by blocking the action of CGRP, thus reducing the frequency, severity, and duration of migraine episodes.
Before you buy Vyepti, it is crucial that you talk to your healthcare provider about potential side effects and Vyepti cost.
| Fact Table | |
|---|---|
| Formula | C6352H9838N1694O1992S46 |
| License | US DailyMed |
| Bioavailability | 100% |
| Legal status | Prescription drug |
| Chemical Name | Eptinezumab |
| Elimination half-life | 27 days |
| Dosage (Strength) | 100mg/mL |
| Pregnancy | Consult a doctor |
| Brands | Vyepti |
| Protein binding | Unknown |
| PubChem CID | Not Assigned |
| MedlinePlus | Not Assigned |
| ChEBI | Not Assigned |
| ATC code | N02CD05 |
| DrugBank | DB14040 |
| KEGG | D11303 |
| Routes of administration | Intravenous |
Vyepti dosage is administered as a 100 mg/100 mL or 300 mg/100 mL intravenous infusion over approximately 30 minutes, once every three months. This treatment should only be administered by a healthcare professional in a medical setting equipped to manage potential reactions to the infusion.
Active Ingredient: Eptinezumab.
Vyepti is contraindicated in patients with a history of hypersensitivity to eptinezumab or any of its components. Prior to receiving Vyepti, inform your healthcare provider if you:
Have any allergies to medications.
Are pregnant, planning to become pregnant, or are breastfeeding.
Have any other medical conditions, especially infections or immune system disorders.
Inform your healthcare provider about all the medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Vyepti may interact with other medications, potentially altering the way your medications work or increasing your risk for serious side effects. Currently, there are no well-documented interactions with Vyepti. However, ongoing research may update this information.
Common side effects of Vyepti include:
In rare cases, more serious side effects may occur, such as:
How effective is Vyepti in preventing migraines?
Clinical trials have shown Vyepti to be effective in reducing the frequency of migraine days in adults when administered every three months.
Can I take Vyepti while pregnant or breastfeeding?
The effects of Vyepti during pregnancy and breastfeeding are not fully known. Consult your healthcare provider for a risk assessment.
How quickly does Vyepti work?
Some patients may experience a reduction in migraine frequency in as little as one week after the infusion, with maximum benefits observed over time.
Is there any downtime after receiving a Vyepti infusion?
Most individuals can resume normal activities immediately after the infusion. However, it is recommended to monitor any reactions for a short period post-infusion.
Can Vyepti cure migraines?
Vyepti is not a cure for migraines but is used to reduce the frequency and severity of migraine episodes.
What should I do if I experience a severe side effect?
If you experience severe or life-threatening side effects, seek immediate medical attention.
Is it safe to drive after receiving Vyepti?
Vyepti does not typically affect your ability to drive or operate machinery, but individual reactions to the medication can vary.
How long do I need to continue Vyepti treatment?
The duration of Vyepti treatment depends on your response to the medication and should be discussed with your healthcare provider.
Can children receive Vyepti?
Vyepti is approved for use in adults over 18. Its safety and efficacy in children have not been established.
What happens if I miss a dose?
If a dose is missed, schedule an appointment with your healthcare provider to receive it as soon as possible. Do not double doses.
